Gene Query: GUK1

Dataset Description Geneva Score
Active translatome profiling with RiboLace in MCF7 cells 98.55
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 36.95
Genome wide expression change in LCC2 and MCF-7 cells 34.75
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 32.05
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 28.11
Differential gene expression profiles in imatinib-resistant cell lines 26.44
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 26.14
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 25.77
Differentiation enhances Zika virus infection in neuronal brain cells 25.29
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 23.77
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 22.28
Stem and effector CD8 T-cells from human cancers 22.11
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 21.68
The comparison of high-throughput single-cell RNA-seq methods 21.54
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 21.01
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 20.73
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 20.17
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 19.97
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 19.89
Developmental stage specific chromosome architecture in human erythroid cells 19.89
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 19.82
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 19.58
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 19.19
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 19.19
RNA-seq of naive and primed ES cells (NHSM) 18.9
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 17.76
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 17.7
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 17.61
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 17.58
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 17.28
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 16.82
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 16.65
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 16.46
SLAM-seq for K562 endogenous mRNA decay 16.39
Tracking distinct RNA populations using efficient and reversible covalent chemistry 15.75
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 15.64
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 15.28
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 15.28
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 14.79
Global analysis of enhancer targets: Mosaic-seq 14.58
RNA m5C Methylation in breast cancer using MeRIP-Seq 14.52
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 14.33
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 14.33
U1 snRNP telescripting regulates size-function stratified human genome 14.31
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 14.14
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 14.09
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 14.0
The effect of PPARG inhibition on human angiomyolipoma cells 13.84
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 13.7
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 13.6
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 13.48
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 13.31
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 13.12
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 13.09
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 12.93
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.83
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 12.78
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 12.65
Differential gene expression of human melanoma cells [RNA-seq] 12.48
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 12.48
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.4
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 12.29
Anti-inflammatory effect of indoleacrylic acid (IA) 12.22
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 12.21
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 12.21
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 12.04
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 12.03
CROP-Seq in Primary Human T Cells 11.93
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 11.9
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 11.9
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 11.87
RNA seq comparison between scrambled and shGRP78 cells 11.87
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 11.86
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 11.84
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 11.63
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 11.63
Regulation of highly expressed hCINAP on translatome 11.56
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.54
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.49
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 11.35
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 11.1
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.09
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 11.05
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 11.05
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 11.04
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 11.01
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 11.0
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 10.99
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 10.99
Comprehensive comparative analysis of 5’ end RNA sequencing methods 10.99
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 10.96
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 10.94
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 10.9
LncRNA expression profiling of ischemic stroke patients 10.88
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 10.85
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 10.8
HNF1 regulates critical functions of the human epididymis epithelium. 10.76
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 10.76
G-quadruplex structures mark human regulatory chromatin 10.76
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 10.73
circRNA-sequencing 10.72
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.7
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.7
Studying the selectivity of a small molecule Synucleozid on transcriptome 10.69
MYC dependent mRNA translation shapes gene expression and cell biology 10.67
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 10.67
MEIS1 regulates hematopoiesis in hPSCs 10.58
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 10.56
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.53
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.53
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 10.51
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 10.51
Transcription elongation regulates genome 3D structure 10.37
Gene expression changes due to PARP knockdown in human cells 10.34
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 10.32
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.26
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 10.21
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 10.17
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 10.08
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.06
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 9.81
HEK293 TFAM Knockout Expression Study 9.77
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.74
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 9.67
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 9.67
The human blood-nerve barrier transcriptome 9.65
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 9.64
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.64
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 9.63
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 9.58
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 9.58
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 9.58
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 9.53
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.52
Identification of Atrial Fibrillation associated genes and functional non-coding variants 9.49
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 9.48
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 9.48
RNA sequencing of primary human platelets and in vitro cell lines 9.45
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 9.42
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 9.35
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 9.35
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 9.31
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 9.31
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 9.28
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 9.2
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 9.2
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.17
Functional role of CPPED1 in trophoblasts. 9.16
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 9.14
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 9.13
LncRNA-GAS5 negative regulation of YAP-target genes expression 9.09
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.06
Examining serotonergic neuron differentiation from human iPSCs 9.02
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.98
NRDE2 negatively regulates nuclear exosome functions 8.97
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 8.88
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.88
miR941 overexpression experiment 8.87
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 8.85
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.82
RNA-seq analyses of human prostate cancer cells 8.79
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 8.78
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 8.78
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 8.76
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 8.75
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 8.75
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.74
RNA Sequencing of three pairs of gastric cancer 8.64
Unique features and clinical importance of acute alloreactive immune responses 8.64
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 8.63
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 8.61
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 8.55
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.52
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.51
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.51
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 8.5
Systematic discovery of endogenous human ribonucleoprotein complexes 8.49
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 8.44
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.41
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 8.38
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 8.32
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 8.29
Effect of CHKA knockdown on C4-2 cell transcriptome 8.27
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.27
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.27
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 8.23
Gene expression profiling of leukemia cells following asparagine depletion 8.22
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.19
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 8.18
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 8.04
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 8.0
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.99
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 7.97
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 7.97
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.88
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 7.87
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.85
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 7.83
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 7.79
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 7.79
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 7.77
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 7.76
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 7.74
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 7.74
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.73
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.72
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 7.69
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 7.67
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 7.66
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 7.64
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  7.64
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 7.54
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.53
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 7.53
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.52
PRDM1 inhibits proliferation of human colon cancer organoids 7.49
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 7.46
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 7.4
Global response to chemotherapy-induced apoptosis 7.33
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.31
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.31
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 7.28
Widespread regulated alternative splicing of single codons accelerates proteome evolution 7.27
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.23
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.2
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 7.16
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.12
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 7.1
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 7.1
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 7.06
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 7.05
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 6.97
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 6.95
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.85
Gene expression analysis of human hepatocellular cancers 6.83
Transciptomic profiling of human fetal lung samples 6.77
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.68
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 6.66
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 6.65
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.6
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.59
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 6.57
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 6.53
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 6.53
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 6.53
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 6.51
METTL3 and WTAP 6.5
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 6.5
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 6.47
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.45
Comparative Analysis of Cas9 Activators Across Multiple Species 6.41
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.4
Transcriptome landscape of HeLa response upon triamcinolone acetonide 6.37
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 6.32
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 6.3
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.29
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.29
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 6.29
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 6.23
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 6.23
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.1
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 6.05
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 6.03
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 6.01
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 6.01
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.97
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 5.97
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.93
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.91
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.91
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.83
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 5.82
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.82
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.82
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.82
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.81
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.81
Trans-differentiation of human adult peripheral blood T cells into neurons 5.69
Illumina Total RNA-seq in HeLa 5.69
Gene expression analysis in response to hypoxic pathway inhibition 5.69
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 5.62
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 5.59
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 5.55
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 5.54
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 5.54
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 5.46
Transcriptome analysis of CNS leukemia 5.46
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.43
Cajal bodies are linked to genome conformation 5.32
Cajal bodies are linked to genome conformation [RNA-Seq] 5.32
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 5.25
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.24
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 5.23
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 5.19
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.87
RNAseq of cell lines with knocked in ESR1 mutations 4.86
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.85
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 4.83
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.83
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.83
Measure transcript integrity using RNA-seq data 4.82
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.82
RNA-seq of IL-4 stimulated human keratinocytes 4.78
Effect of PBK knockdown on C4-2 cell transcriptome 4.68
Zika virus directly infects human peripheral neurons and induces cell death 4.67
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 4.64
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.55
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 4.54
Hepatitis C virus functionally sequesters miR-122 4.5
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.5
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.48
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.48
High-throughput sequencing of pluripotent cells 4.47
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.45
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.44
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 4.4
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 4.4
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.4
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 4.38
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 4.38
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 4.38
Ebola virus (EBOV) infection of ARPE-19 cells 4.29
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 4.29
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.23
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.21
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.13
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.06
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 4.04
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.01
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 3.95
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 3.93
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.9
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.9
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.88
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.86
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.82
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.82
Hepatocyte maturation 3.8
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.79
An optimization system for isolating and sequencing of single human colon cancer cells 3.79
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.72
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.67
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.65
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.65
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.55
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.42
TT-Seq captures the human transient transcriptome 3.41
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.41
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 3.39
Activity-dependent transcriptional changes in human neurons 3.37
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.37
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.35
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.35
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.34
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.32
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.32
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.32
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 3.31
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 3.3
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.25
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.25
K562 polyA RNA-Seq 3.25
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 3.25
miR-93 Targets in Human Endothelial Cells 3.23
Transcriptome sequencing of K-562 cells 3.14
Differential responses of human fetal brain neural stem cells to Zika virus infection 3.1
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.04
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.01
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.99
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.96
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.95
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.89
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.87
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.87
A single-cell transcriptome atlas of the human pancreas 2.84
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.82
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.8
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.76
Positively selected enhancer elements endow tumor cells with metastatic competence 2.75
Expression profiling of MCF-7 cells with treatment of TCDD 2.71
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.71
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.71
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.67
Gene expression analysis upon mtDNA depletion 2.67
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.67
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.66
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.65
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.65
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.53
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.53
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.45
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.42
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 2.4
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 2.35
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 2.35
RNA editing in nascent RNA affects pre-mRNA splicing 2.34
Toxoplasma gondii infection of human retinal pigment epithelial cells 2.33
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.31
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.25
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.24
Effect of FGF13 depletion on the H460 cell line 2.23
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.22
Gene expression profile in breast cancer cells 2.22
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.19
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.16
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.15
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.14
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.12
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.12
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.07
ChIP-seq and RNA-seq from human lymphoma cell lines 2.0
RNA-seq data from human lymphoma cell lines 2.0
SRSF1 role in cellular gene expression and splicing 2.0
MicroRNA-125a-5p overexpression in human macrophages 2.0
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.98
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.92
ML29755 RNA-seq data 1.88
Ectoderm specification of H1 human embryonic stem cells 1.79
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.77
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.67
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.67
RNA-seq differential expression studies: more sequence, or more replication? 1.65
Transcriptomes in healthy and CHB fetal hearts 1.56
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.5
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.5
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.49
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.49
Profiling of escape kinetics of viruses subjected to RNAi 1.41
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.39
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.35
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.34
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.27
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.24
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.24
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.24
Identification of a LIF-responsive replication-competent human β cell 1.24
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.22
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.19
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.18
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.14
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.09
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 1.06
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.04
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.01
Copper Regulation of HIF-1 Transcription Activity 1.01
0.99
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.97
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.94
Transcriptome analysis upon C6orf203 silencing 0.92
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.87
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.87
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.82
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.82
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.81
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.81
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.81
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.78
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.78
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.78
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.77
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.72
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.69
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.67
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.63
Ribosome profiling upon inhibition of eIF4A 0.6
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.6
The role of m6A/m-RNA methylation in stress response regulation 0.6
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.58
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.58
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.54
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.53
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.53
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.52
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.51
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.51
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.49
EGR1-controlled transcriptome of T HESCs 0.44
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.43
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.43
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.43
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.37
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.34
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.31
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.3
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.3
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.29
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.27
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.27
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.14
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.14
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.12
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.09
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.07
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.06
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.05
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.04
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.03
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.03
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation